Breast cancer remains the most common type of cancer in females, with survival rates decreasing sharply for those with distant metastases.
MMP2, a type of enzyme that degrades the extracellular matrix, has previously been implicated in the development of distant tumour metastases, but without a clearly defined role.
In the Journal of Pathology, Barbara Fingleton, Ph.D., and colleagues establish a role for MMP2 in the development of lung metastases from primary breast cancer.
Using mice without the Mmp2 gene, the team found that metastatic tumours in the lung proliferate less in the absence of fibroblast MMP2.
The researchers showed that one function of MMP2 in lung metastasis is the regulation of fibroblast activation and collagen expression.
They suggest that MMP2 generates active TGFbeta-1, and showed that supplying active TGFbeta-1 restores collagen expression in Mmp2-deficient fibroblasts.
Source: Vanderbilt-Ingram Cancer Center
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.